Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Hong Kong
· Delayed Price · Currency is HKD 8.63
+0.05 (0.58%)
Mar 10, 2026, 3:55 PM HKT
HKG:3613 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 7,182 | 7,350 | 10,162 | 9,593 | 11,234 | 6,822 | Upgrade
|
| Market Cap Growth | 3.00% | -27.68% | 5.93% | -14.61% | 64.66% | -30.70% | Upgrade
|
| Enterprise Value | 5,496 | 5,854 | 7,971 | 7,478 | 9,519 | 5,203 | Upgrade
|
| Last Close Price | 8.58 | 8.43 | 11.26 | 10.41 | 11.55 | 6.89 | Upgrade
|
| PE Ratio | 13.94 | 14.69 | 18.81 | 14.85 | 18.48 | 12.58 | Upgrade
|
| Forward PE | 13.41 | 10.53 | 12.37 | 15.43 | 17.23 | 12.43 | Upgrade
|
| PS Ratio | 4.20 | 4.56 | 6.66 | 5.54 | 7.22 | 5.19 | Upgrade
|
| PB Ratio | 1.70 | 1.73 | 2.53 | 2.57 | 3.17 | 2.18 | Upgrade
|
| P/TBV Ratio | 1.81 | 1.83 | 2.67 | 2.71 | 3.35 | 2.30 | Upgrade
|
| P/FCF Ratio | 13.85 | - | 23.15 | 18.85 | 14.90 | 66.13 | Upgrade
|
| P/OCF Ratio | 12.66 | - | 22.05 | 17.52 | 14.46 | 58.79 | Upgrade
|
| PEG Ratio | - | 0.69 | 0.69 | 0.69 | 0.69 | 0.69 | Upgrade
|
| EV/Sales Ratio | 3.22 | 3.63 | 5.23 | 4.32 | 6.12 | 3.96 | Upgrade
|
| EV/EBITDA Ratio | 8.11 | 9.87 | 12.44 | 9.13 | 12.10 | 7.81 | Upgrade
|
| EV/EBIT Ratio | 9.32 | 10.20 | 12.78 | 9.30 | 12.33 | 8.08 | Upgrade
|
| EV/FCF Ratio | 10.59 | - | 18.16 | 14.69 | 12.63 | 50.43 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 0.21 | 0.19 | 0.19 | 0.12 | 0.15 | 0.15 | Upgrade
|
| Debt / FCF Ratio | 0.28 | - | 0.30 | 0.20 | 0.17 | 1.03 | Upgrade
|
| Net Debt / Equity Ratio | -0.44 | -0.40 | -0.56 | -0.58 | -0.61 | -0.56 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.14 | -2.88 | -3.54 | -2.64 | -2.75 | -2.64 | Upgrade
|
| Net Debt / FCF Ratio | -3.62 | 6.57 | -5.16 | -4.24 | -2.87 | -17.06 | Upgrade
|
| Asset Turnover | 0.39 | 0.36 | 0.35 | 0.43 | 0.43 | 0.40 | Upgrade
|
| Inventory Turnover | 0.41 | 0.42 | 0.65 | 1.29 | 0.94 | 0.89 | Upgrade
|
| Quick Ratio | 11.32 | 10.02 | 8.55 | 7.66 | 13.31 | 11.14 | Upgrade
|
| Current Ratio | 18.17 | 16.85 | 11.65 | 8.80 | 15.38 | 13.54 | Upgrade
|
| Return on Equity (ROE) | 13.06% | 12.80% | 15.22% | 19.00% | 19.54% | 19.27% | Upgrade
|
| Return on Assets (ROA) | 8.24% | 7.98% | 9.01% | 12.48% | 13.31% | 12.27% | Upgrade
|
| Return on Invested Capital (ROIC) | 20.85% | 22.48% | 32.14% | 45.58% | 47.11% | 47.43% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.40% | 13.30% | 15.20% | 21.10% | 21.30% | 20.10% | Upgrade
|
| Earnings Yield | 7.18% | 6.81% | 5.32% | 6.73% | 5.41% | 7.95% | Upgrade
|
| FCF Yield | 7.22% | -3.54% | 4.32% | 5.30% | 6.71% | 1.51% | Upgrade
|
| Dividend Yield | 4.08% | 4.15% | 2.93% | 3.17% | 2.42% | 3.48% | Upgrade
|
| Payout Ratio | 56.85% | 55.22% | 51.12% | 36.29% | 33.05% | 35.49% | Upgrade
|
| Total Shareholder Return | 4.08% | 4.15% | 2.93% | 3.17% | 2.42% | 3.48% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.